# ALNEO (NCT05015010)

> Alectinib in Neo-adjuvant Treatment of Stage III NSCLC

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT05015010
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica
- Conditions: Non Small Cell Lung Cancer
- Interventions: Alectinib
- Enrollment: 33
- Primary outcome: Major Pathological Response (MPR)

## Commentary we found

- X threads: 18
- YouTube: 12
- Podcasts: 9

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=alneo-nct05015010

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT05015010", "email": "<work email>"}; the inbox owner confirms by the emailed link.